Apr.20 — Min-Han Tan, founding chief executive officer and medical director of Singapore-based Lucence Diagnostics Pte, talks about the medical device for coronavirus diagnosis the company began developing. The Stabilization of nucleic Acid Formulation for Evaluation of RNA, or SAFER, kit is a sample-collection device to facilitate more accessible testing of viral infections such as COVID-19. Tan speaks on “Bloomberg Markets: Asia.” …read more
Source:: Yahoo Finance
